Self-complementary recombinant adeno-associated virus (scAAV) vectors promote efficient transduction independently of DNA synthesis
The DOI matches its Crossref record; 34 of the 34 references it cites were found in a registry or an index.
Abstract
Adeno-associated virus (AAV) vectors package single-stranded genomes and require host-cell synthesis of the complementary strand for transduction. However, when the genome is half wild-type size, AAV can package either two copies, or dimeric inverted repeat DNA molecules. Dimeric, or self-complementary molecules (scAAV) should spontaneously reanneal, alleviating the requirement for host-cell DNA synthesis. We generated and characterized scAAV vectors in order to bypass the rate-limiting step of second-strand synthesis. In vitro, scAAV vectors were five- to 140-fold more efficient transducing agents than conventional rAAV, with a 5.9:1 particle to transducing unit ratio. This efficiency is neither greatly increased by co-infection with Ad, nor inhibited by hydroxyurea, demonstrating that transduction is independent of DNA synthesis. In vivo, scAAV expressing erythropoietin resulted in rapid and higher levels of hematocrit than a conventional single-stranded vector. These novel scAAV vectors represent a biochemical intermediate in rAAV transduction and should provide new insights into the biology of vector transduction.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“ScAAV mediated transgene expression could be enhanced by 5 up to 140 fold in vitro [254], and a further 90% increase in the yield of dimeric genomes was be achieved by deletion of the terminal resolution site sequence from one ITR (ITR2∆) [255].”
From Recombinant Adeno-Associated Viral Vectors (rAAV)-Vector Elements in Ocular Gene Therapy Clinical Trials and Transgene Expression and Bioactivity Assays (2020) · cites this paper as [254]
In the citing paper
“However, this obstacle has been circumvented by the development of self-complementary AAV (scAAV) [10, 11].”
From Designing and optimizing AAV-mediated gene therapy for neurodegenerative diseases: from bench to bedside (2024) · cites this paper as [11]
Citations
Cites
Xiao, X., Li, J., & Samulski, R. J. (1998) · Journal of Virology · doi:10.1128/jvi.72.3.2224-2232.1998 · Cited by 1,381
Self-citationZolotukhin, S., Byrne, B. J., Mason, E., Zolotukhin, I., Potter, M., Chesnut, K., Summerford, C., Samulski, R. J., & Muzyczka, N. (1999) · Gene Therapy · doi:10.1038/sj.gt.3300938 · Cited by 1,312
Self-citationFerrari, F. K., Samulski, T., Shenk, T., & Samulski, R. J. (1996) · Journal of Virology · doi:10.1128/jvi.70.5.3227-3234.1996 · Cited by 761
Self-citationUse of Adeno-Associated Virus as a General Transduction Vector for Mammalian Cells
Muzyczka, N. (1992) · Current Topics in Microbiology and Immunology · doi:10.1007/978-3-642-75608-5_5 · Cited by 754
Quantitative analysis of the packaging capacity of recombinant adeno-associated virus
Dong, J.-Y., Fan, P.-D., & Frizzell, R. A. (1996) · Human Gene Therapy · doi:10.1089/hum.1996.7.17-2101 · Cited by 583
Snyder, R. O., Miao, C. H., Patijn, G. A., Spratt, S. K., Danos, O., Nagy, D., Gown, A. M., Winther, B., Meuse, L., Cohen, L. K., et al. (1997) · Nature Genetics · doi:10.1038/ng0797-270 · Cited by 579
Fisher, K. J., Gao, G. P., Weitzman, M. D., DeMatteo, R., Burda, J. F., & Wilson, J. M. (1996) · Journal of Virology · doi:10.1128/jvi.70.1.520-532.1996 · Cited by 547
Current protocols in human genetics
Bates, G. (1995) · Trends in Genetics · doi:10.1016/s0168-9525(00)89147-7 · Cited by 482
McCown, T. J., Xiao, X., Li, J., Breese, G. R., & Jude Samulski, R. (1996) · Brain Research · doi:10.1016/0006-8993(95)01488-8 · Cited by 450
Self-citationSamulski, R. J., Chang, L. S., & Shenk, T. (1987) · Journal of Virology · doi:10.1128/jvi.61.10.3096-3101.1987 · Cited by 449
Self-citationBiology of Adeno-associated Virus
Berns, K. I., & Giraud, C. (1996) · Current Topics in Microbiology and Immunology · doi:10.1007/978-3-642-80207-2_1 · Cited by 305
Löser, P., Jennings, G. S., Strauss, M., & Sandig, V. (1998) · Journal of Virology · doi:10.1128/jvi.72.1.180-190.1998 · Cited by 279
Palindromic base sequences and replication of eukaryote chromosome ends
Cavalier-Smith, T. (1974) · Nature · doi:10.1038/250467a0 · Cited by 275
Alexander, I. E., Russell, D. W., & Miller, A. D. (1994) · Journal of Virology · doi:10.1128/jvi.68.12.8282-8287.1994 · Cited by 222
DNA synthesis and topoisomerase inhibitors increase transduction by adeno-associated virus vectors.
Russell, D. W., Alexander, I. E., & Miller, A. D. (1995) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.92.12.5719 · Cited by 218
DNA amplification of adeno-associated virus as a response to cellular genotoxic stress.
Yalkinoglu, A. Ö., Heilbronn, R., Bürkle, A., Schlehofer, J. R., & Hausen, H. Z. (1988) · PubMed · Cited by 218
Replication of adeno-associated virus in synchronized cells without the addition of a helper virus
Yakobson, B., Koch, T., & Winocour, E. (1987) · Journal of Virology · doi:10.1128/jvi.61.4.972-981.1987 · Cited by 214
Halbert, C. L., Standaert, T. A., Aitken, M. L., Alexander, I. E., Russell, D. W., & Miller, A. D. (1997) · Journal of Virology · doi:10.1128/jvi.71.8.5932-5941.1997 · Cited by 205
Nakai, H., Storm, T. A., & Kay, M. A. (2000) · Journal of Virology · doi:10.1128/jvi.74.20.9451-9463.2000 · Cited by 194
Straus, S. E., Sebring, E. D., & Rose, J. A. (1976) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.73.3.742 · Cited by 194
The kinetics of rAAV integration in the liver
Miao, C. H., Snyder, R. O., Schowalter, D. B., Patijn, G. A., Donahue, B., Winther, B., & Kay, M. A. (1998) · Nature Genetics · doi:10.1038/ng0598-13 · Cited by 186
Rose, J. A., Berns, K. I., Hoggan, M. D., & Koczot, F. J. (1969) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.64.3.863 · Cited by 179
Replication of adeno-associated virus in cells irradiated with UV light at 254 nm
Yakobson, B., Hrynko, T. A., Peak, M. J., & Winocour, E. (1989) · Journal of Virology · doi:10.1128/jvi.63.3.1023-1030.1989 · Cited by 139
Design and Packaging of Adeno-Associated Virus Gene Targeting Vectors
Hirata, R. K., & Russell, D. W. (2000) · Journal of Virology · doi:10.1128/jvi.74.10.4612-4620.2000 · Cited by 133
Miao, C. H., Nakai, H., Thompson, A. R., Storm, T. A., Chiu, W., Snyder, R. O., & Kay, M. A. (2000) · Journal of Virology · doi:10.1128/jvi.74.8.3793-3803.2000 · Cited by 130
Alexander, I. E., Russell, D. W., Spence, A. M., & Miller, A. D. (1996) · Human Gene Therapy · doi:10.1089/hum.1996.7.7-841 · Cited by 124
Berns, K. I., & Rose, J. A. (1970) · Journal of Virology · doi:10.1128/jvi.5.6.693-699.1970 · Cited by 120
Berns, K. I., & Adler, S. (1972) · Journal of Virology · doi:10.1128/jvi.9.2.394-396.1972 · Cited by 101
Rose, J. A., & Koczot, F. (1972) · Journal of Virology · doi:10.1128/jvi.10.1.1-8.1972 · Cited by 74
High adenoviral loads stimulate NFκB-dependent gene expression in human vascular smooth muscle cells
Clesham, G., Adam, P., Proudfoot, D., Flynn, P., Efstathiou, S., & Weissberg, P. (1998) · Gene Therapy · doi:10.1038/sj.gt.3300576 · Cited by 66
Molecular structure of adeno-associated virus variant DNA.
de la Maza, L. M., & Carter, B. J. (1980) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)85870-2 · Cited by 61
Production of Recombinant Adeno-Associated Virus Vectors
Zolotukhin, S. (2005) · Human Gene Therapy · doi:10.1089/hum.2005.16.551 · Cited by 49
Lusby, E., Bohenzky, R., & Berns, K. I. (1981) · Journal of Virology · doi:10.1128/jvi.37.3.1083-1086.1981 · Cited by 46
Biology of Adeno-Associated Virus
Cukor, G., Blacklow, N. R., HOGGAN, M. D., & Berns, K. I. (1984) · Springer eBooks · doi:10.1007/978-1-4684-8012-2_2 · Cited by 35
Research works printed but not linked: 1
- Berns KI . Parvorviridae and their replication. In: Fields BN, Knipe DM (eds) Virology, 2nd edn Raven: New York 1990 pp 1743–1763
Cited by
Progress and problems with the use of viral vectors for gene therapy
Thomas, C. E., Ehrhardt, A., & Kay, M. A. (2003) · Nature Reviews Genetics · doi:10.1038/nrg1066 · Cited by 2,501
Fatality in mice due to oversaturation of cellular microRNA/short hairpin RNA pathways
Grimm, D., Streetz, K. L., Jopling, C. L., Storm, T. A., Pandey, K., Davis, C. R., Marion, P., Salazar, F., & Kay, M. A. (2006) · Nature · doi:10.1038/nature04791 · Cited by 1,677
Adeno-Associated Virus (AAV) as a Vector for Gene Therapy
Naso, M. F., Tomkowicz, B., Perry, W. L., & Strohl, W. R. (2017) · BioDrugs · doi:10.1007/s40259-017-0234-5 · Cited by 1,362
“After delivery to the nucleus, the single-stranded transgene needs to be converted into a double-stranded transgene, which is considered a limiting step in the onset of transgene expression [13].”
BackgroundAdeno-associated Virus Serotypes: Vector Toolkit for Human Gene Therapy
Wu, Z., Asokan, A., & Samulski, R. J. (2006) · Molecular Therapy · doi:10.1016/j.ymthe.2006.05.009 · Cited by 922
Self-citationGene therapy using adeno-associated virus vectors
Daya, S., & Berns, K. I. (2008) · Clinical Microbiology Reviews · doi:10.1128/cmr.00008-08 · Cited by 926
Metadata
- Authors
- McCarty, D., Monahan, P., & Samulski, R.
- Affiliations
- University of North Carolina at Chapel Hill (US)
- Venue
- Gene Therapy
- Published
- 2001-08-01
- Volume
- 8
- Issue
- 16
- Pages
- 1248-1254
- ISSN
- 0969-7128 (ISSN-L)
- 1476-5462
- OpenAlex
- W2056602419
- Cited by
- 735
- References
- 34
- Citations by year
- 2026: 23 · 2025: 22 · 2024: 30 · 2023: 30 · 2022: 28 · 2021: 33 · 2020: 47 · 2019: 36 · 2018: 33 · 2017: 45 · 2016: 37 · 2015: 45 · 2014: 31 · 2013: 30 · 2012: 41
- FWCI
- 6.93
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- www.springer.com/tdm (vor)
- Locations
- Gene Therapy (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Hemophilia Foundation
- National Institutes of Health (5r01hl048347-09)
- National Heart, Lung, and Blood Institute (P01HL051818, HL 03960, HL 48347, HL51818)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Virus-based gene therapy research
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › RNA Interference and Gene Delivery
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Viral Infectious Diseases and Gene Expression in Insects
- Keywords
- self-complementary AAV vectors, recombinant adeno-associated virus, AAV transduction, transduction efficiency, hematocrit, hydroxyurea
- MeSH terms
- Dependovirus, Animals, Cell Line, DNA, Viral, Erythropoietin, Genetic Engineering, Genetic Vectors, HeLa Cells, Hematocrit, Humans, Liver, Luminescent Proteins, Mice, Inbred BALB C, Transduction, Genetic, Gene Expression, DNA, Complementary, Green Fluorescent Proteins, Mice
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.